See how the New EnSight™ System can Accelerate Your Research at ELRIG Drug Discovery and Miptec

Visit PerkinElmer at booth K5+K6 at ELRIG Drug Discovery, Manchester, UK, September 2-3, and booth C61 at Miptec, Switzerland, September 23-25, to see the new EnSight™ Multimode Plate Reader…

EnSight™ Multimode Plate Reader is the first benchtop system to offer well-imaging alongside label-free and labeled detection technologies. The EnSight™ supports a broad range of applications, in areas such as cancer, cytotoxicity, biotherapeutics, epigenetics and primary/stem cells, with a unique combination of technologies:

• Well-imaging
• Epic® Label-free
• Alpha Technology
• Ultra-Sensitive Luminescence
• Absorbance (filter and monochromator)
• Fluorescence (top- and bottom-reading)
• Time-Resolved Fluorescence (TRF)

The combination of technologies for target-based and phenotypic approaches allows you take a truly orthogonal approach to your research. Not only can you perform a wide range of assays on a single system, but you can also confirm your findings using different technologies for greater confidence that your results are biologically relevant, not biased to a technology.

Discover how EnSight can enable more predictive data earlier in the drug discovery process, by visiting our booths at both shows.